In fact, these cells express mutant TP53 (R248Q) (Table 1) and can be considered a cellular model representative of the majority of ovarian cancer patients bearing mutations in TP53 sequence (96% of the cases reported in TCGA patients’ cohort) (Figure 4A). Here, TP53 is linked to ovarian carcinoma.